Company Filing History:
3 out of 896 
2 out of 233 
Years Active: 2010-2016
Title: **Inventor Spotlight: Shin-Tai Chen**
Introduction
Shin-Tai Chen, based in Colton, California, is a distinguished inventor known for his significant contributions to the field of osteogenic gene therapy. With a total of three patents, Chen's work focuses on innovative compositions and methods aimed at promoting bone growth and enhancing wound healing, particularly in the context of fracture repair.
Latest Patents
Chen's latest patents revolve around compositions and methods for osteogenic gene therapy. The disclosure provides recombinant nucleic acids that promote bone growth and healing. For instance, these nucleic acids encode a fibroblast growth factor-2 (FGF-2) analog, which plays a crucial role in increasing bone growth and accelerating wound healing processes. Moreover, the patents outline a unique mouse system for bone marrow transplantation, detailing both the methods for producing this system and its applications. Chen's work also includes techniques for inducing the division and differentiation of hematopoietic stem cells, emphasizing methods that further enhance bone growth and repair.
Career Highlights
Throughout his career, Shin-Tai Chen has collaborated with reputable institutions, enhancing his research's impact and applications. Notably, he has contributed his expertise while working with the United States Government as represented by the Department of Veterans Affairs, as well as Loma Linda University. His commitment to research and development has established him as a prominent figure in genetic therapies related to bone health.
Collaborations
During his work, Chen has collaborated with notable coworkers, including Kin-Hing William Lau and David J. Baylink. These partnerships have enabled synergistic advancements in the research and practical applications of his innovative inventions, fostering a collaborative environment that enhances scientific discovery.
Conclusion
In summary, Shin-Tai Chen's contributions to osteogenic gene therapy represent the forefront of innovation in medical science. With his patents focused on enhancing bone growth and wound healing, Chen continues to push the boundaries of biomedical research, ensuring that his inventions have a lasting impact on both science and medicine.